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Abstract
Outcome estimation of treatments for target individuals is an important foundation
for decision making based on causal relations. Most existing outcome estimation meth-
ods deal with binary or multiple-choice treatments; however, in some applications, the
number of treatments can be significantly large, while the treatments themselves have
rich information. In this study, we considered one important instance of such cases: the
outcome estimation problem of graph-structured treatments such as drugs. Owing to
the large number of possible treatments, the counterfactual nature of observational data
that appears in conventional treatment effect estimation becomes more of a concern
for this problem. Our proposed method, GraphITE (pronounced “graphite”) learns the
representations of graph-structured treatments using graph neural networks while miti-
gating observation biases using Hilbert-Schmidt Independence Criterion regularization,
which increases the independence of the representations of the targets and treatments.
Experiments on two real-world datasets show that GraphITE outperforms baselines,
especially in cases with a large number of treatments.
Fig. 1: Individual effect estimation problem of graph-structured treatments. The pos-
sible treatments, i.e., drugs, are associated with graphs representing their molecular
structures. In observational data, only one treatment is applied to the target individual;
consequently, only the factual outcome is observed, while the counterfactual outcomes
for the other treatments are not. Our goal is to predict the outcomes of all treatments
for future targets.
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1 Introduction
Estimating causal effects of treatments for individual targets is an important founda-
tion for effective decision making based on observational data. The major difficulties
in ITE estimation are (i) the counterfactual nature of observational data, i.e., only the
outcome of the actual treatment is observed and (ii) biases in datasets due to the bi-
ases in past treatment decisions. To address these difficulties, various techniques have
been developed, including matching (Rubin, 1973), inverse propensity score weight-
ing (Rosenbaum and Rubin, 1983), instrumental variable methods (Baiocchi, Cheng,
and Small, 2014), as well as more modern representation learning approaches (Shalit,
Johansson, and Sontag, 2017; Johansson, Shalit, and Sontag, 2016).
Most previous studies dealt with binary or relatively small numbers of treatments.
However, in some scenarios, the number of treatments can be considerably larger. For
example, when modeling the effects of drugs on target cells, the number of candidate
drugs (i.e., treatments) can be large, and the number of observations per drug can
be small due to the high cost of clinical trials (Ganter et al., 2005; Hoelder, Clarke,
and Workman, 2012); a similar situation can also occur in advertisement (Saini et al.,
2019). Such data scarcity exacerbates the above problems.
In this study, we consider the individual treatment effect estimation problem with
a large number of treatments, for which there is no definitive existing solution. To solve
the problem, we focus on auxiliary information accompanying the treatments, which
is sometimes available. In the drug effect example, each drug is a chemical compound
with its own molecular structure, which can be represented as a graph (Fig. 1). The rich
structural information of graphs allows us to transfer useful information for predicting
outcomes from treatments with many observations to those with less observations.
We propose GraphITE (pronounced “graphite”), which is an outcome prediction
model for graph-structured treatments based on biased observational data. It is built
upon the recent significant advances in learning representations from graphs using
graph neural networks (GNNs) (Kipf and Welling, 2016; Gilmer et al., 2017). Bias
mitigation with a large (possibly infinite) number of treatments is another issue because
most existing frameworks (Shalit, Johansson, and Sontag, 2017; Schwab, Linhardt, and
Karlen, 2018; Saini et al., 2019) are not designed for such cases. To reduce the treatment
selection bias depending on the individual target, GraphITE finds representations of
the target and treatment that are as independent of each other as possible. This is
achieved by Hilbert-Schmidt Independence Criterion (HSIC) regularization, which was
recently proposed by Lopez et al. (2020); its framework allows us to extend it to exploit
the treatment features extracted by a GNN.
We conduct experiments on two real datasets: one with a relatively small num-
ber of treatments and one with over 100 treatments. The results show that the graph
structures contribute to improving the predictive performance and that the HSIC reg-
ularization is robust to the presence of selection bias.
The contributions of this study can be summarized:
– We propose GraphITE, an outcome prediction model for graph-structured treat-
ments. To the best of our knowledge, this is the first model to exploit auxiliary
information of treatments to deal with a large number of treatments.
– We apply HSIC regularization to cases where treatments have features, to train
GraphITE from biased observational data.
– Experiments on two real-world datasets empirically demonstrate the benefits of
GraphITE.
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2 Problem Definition
We consider the problem of estimating the outcomes of treatments with graph struc-
tures from biased observational data. Let D = {(xi, ti, ytii )}Ni=1 ∈ X ×T ×Y be a biased
observational dataset, where xi ∈ X is the covariate vector of the i-th target individual,
ti ∈ T is the treatment performed on the target individual, and ytii is the outcome.1
We assume the covariate space X = RD, treatment space T = {1, 2, . . . , |T |}, and
outcome space Y = R. In addition to D, we assume each treatment j ∈ T is associated
with a graph Gj = (Vj , Ej), where Vj denotes a set of nodes and Ej ⊆ Vj ×Vj denotes
a set of edges. We denote the set of the treatment graphs by G = {Gj}|T |j=1. Our goal is
to, given D and G, estimate an outcome prediction function f : X × T → Y.
Figure 1 illustrates our problem setting in the context of medical treatments. In
the observational data, there are multiple drugs that could be applied to the target
individual, where each drug corresponds to a treatment and is associated with a graph
representing its molecular structure. Only the outcome ytii for the actual prescribed
drug ti (i.e., the factual outcome) is observed, and those for the other drugs (i.e.,
counterfactual outcomes) are not observed. Because a doctor prescribes a drug based
on the condition of the target patient xi, there is a bias in the choice of ti in the
observational data.
A potential difficulty in our problem is that the number of treatments can be large,
say |T | > 100; it is clear that this can cause a data scarcity issue. In our scenario,
graphs are available as auxiliary information for the treatments, which potentially help
in dealing with such a large number of treatments.
Following the existing work, we make the typical assumptions in the Rubin-Neyman
framework (Rubin, 2005): (i) Stable unit treatment value; the outcome of each instance
is not affected by the treatments assigned to other instances. (ii) Unconfoundedness; the
treatment assignment to an instance is independent of the outcome given the covariates
(i.e., the confounder variables). (iii) Overlap; each instance has a positive probability
of treatment assignment, i.e., ∀x, t, p(x, t) > 0.
3 GraphITE
Previous studies on individual treatment effect estimation have not considered rich
information associated with treatments, which in our case is given as graphs. We ex-
pect that the use of such auxiliary information will be effective, especially when the
number of treatments is relatively high and the training dataset is biased. We propose
GraphITE, which utilizes graph-structured treatments while reducing selection bias
effectively. We first introduce the network architecture of GraphITE, and then apply
HSIC regularization to estimate outcomes appropriately from a biased dataset.
3.1 Model
The model of GraphITE consists of three components: two mapping functions φ : X →
Φ and ψ : T → Ψ for extracting representations of the input and treatment graph,
respectively, and a prediction function g : Φ×Ψ → Y for predicting the outcome, where
Φ and Ψ are the latent representation spaces of the inputs and treatments induced by φ
and ψ, respectively. Figure 2 illustrates the overview of the neural network architecture.
1 Owing to the counterfactual nature of the problem, we are unable to observe the
outcomes of the other treatments as they are not performed.
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Fig. 2: GraphITE model architecture. A target individual x ∈ X and graph-structured
treatment t ∈ T are taken as the inputs. The φ and ψ map them to the low-dimensional
representations, where φ is a standard feed-forward neural network and ψ is a graph
neural network. The two representation vectors φ(x) and ψ(t) are concatenated to be
an input to another feed-forward network g, which predicts the outcome y.
As mentioned earlier, the mapping function ψ extracts representations that capture
the features of graph-structured treatments. If we simply take ψ as a one-hot encoding
of discrete treatments, it coincides with the standard setting with multiple treatments;
however, this approach cannot take advantage of the rich structural information that
the graph treatments have, and therefore suffers from a large number of treatments.
As the mapping function ψ of the treatment graphs, we employ a GNN. GNNs have
been successfully applied in various domains (Duvenaud et al., 2015; Kipf and Welling,
2016; Gilmer et al., 2017) and are capable of extracting features of graphs owing to the
flexible expressive power of neural networks optimized in an end-to-end manner.
The representation vector of graph-structured treatment G = (V, E) is otained as
follows. First, for each node vk ∈ V, the representation of vk is initialized to a low-
dimensional vector v
(0)
k ∈ RDΨ determined by randomized initialization depending
on the node label, such as the atom type. At the c-th layer of the GNN, the node
representations are updated using
v
(c)
k = σ
V
Wv(c−1)k + ∑
vm∈Nk
Mv(c−1)m
 , (1)
where σV is an activation function, such as the ReLU function, Nk is the set of nodes
adjacent to vk, and W and M are transformation matrices. After the updates through
C layers, the representations of all the nodes are aggregated into a graph-level repre-
sentation ψ(G) as
ψ(G) =
∑
vk∈V
σG
(
C∑
c=0
v
(c)
k
)
, (2)
where σG is an activation function, such as the softmax function.
Note that, as we will see later, we require the treatment mapping function to be in-
vertible, i.e., one-to-one, which most GNNs are not; howwever, some recent studies have
proposed GNNs with the one-to-one property (Murphy et al., 2019; Zang and Wang,
2020). In our experiments, we use a non-invertible GNN which exhibits satisfactory
performance.
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3.2 Bias mitigation using HSIC regularization
With a non-biased dataset collected through randomized controlled trials (RCT), it
suffices to minimize the objective function
N∑
i=1
`(ytii , g(φ(xi), ψ(ti)) (3)
to estimate the components of GraphITE, φ, ψ, and g, where ` is a loss function, such as
mean squared error (MSE). However, the objective function is biased when the training
dataset is biased, and we must adjust it to mitigate the negative effect.
We first propose our approach from an intuitive viewpoint. The main source of the
bias is that, in contrast with RCT, the treatments in the observational data are selected
depending on the target individuals (i.e., the covariates). Our idea for mitigating the
bias is to reduce the dependency, i.e., to find representations of the target and treatment
that are as independent of each other as possible. To implement this idea, we employ
HSIC (Gretton et al., 2001) to measure the independence; the HSIC is defined as
HSIC(φ, ψ) = (N − 1)−2tr(KΦHKΨH), (4)
where KΦ and KΨ are the kernel matrices of the representations of the targets and
treatments, respectively, and H is the centering matrix H = I − 1
N
1. If the kernel
function is characteristic, HSIC becomes 0 in expectation if and only if the two repre-
sentations are independent; we use the Gaussian kernel as the kernel function.
With the HSIC as a regularization term, our objective function is modified to
N∑
i=1
`(ytii , g(φ(xi), ψ(ti)) + λ HSIC(φ, ψ), (5)
where λ is the regularization hyper-parameter. The φ is implemented as a standard
feed-forward neural network, while ψ is a GNN; the φ and ψ are concatenated as an
input to g that is another feed-forward network. The objective function (5) is optimized
in a mini-batch manner using Adam (Kingma and Ba, 2014), where the loss function
and HSIC term are approximated by B observations in a mini batch.
Finally, we give some historical remarks explaining why we specifically chose the
HSIC as the regularization term, which itself is not quite a new idea. Previous stud-
ies have considered a broad class of regularization terms, integral probability metrics
(IPMs) (Johansson, Shalit, and Sontag, 2016; Shalit, Johansson, and Sontag, 2017);
however, they basically assume a binary treatment or a relatively small number of
treatments, and they cannot be directly applied to a large number of treatments. For
example, typical IPMs such as the maximum mean discrepancy (MMD) and Wasser-
stein distance, require many regularization terms for all pairs of treatments; otherwise,
an expedient “pivot” control treatment must be set, which is not effective, as demon-
strated in our experiments. The use of the HSIC is proposed by Lopez et al. (2020)
as it naturally allows multiple treatments. However, they did not consider learning
representations of treatments.
3.3 Theoretical justification of HSIC regularization
Now we consider the theoretical justification for using the HSIC in GraphITE. Our
discussion is based on the theory of Lopez et al. (2020) and one of its extensions to
graph-structured treatments.
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Table 1: Performance comparison of different methods on the CCLE and GDSC dataset
in terms of RMSE and CI. † and ‡ indicate statistically significantly better performance
of the proposed GraphITE than the baseline by the paired t-test with p < 0.05 and
p < 0.01, respectively. The bold results indicate the best average results. The shaded
rows indicate the GNN-based methods. Lower RMSEs are better, and higher CIs are
better.
CCLE GDSC
Method RMSE CI RMSE CI
Mean ‡3.777±0.101 − ‡4.030±0.102 −
OLS ‡4.861±0.755 ‡0.642±0.021 ‡6.463±0.493 ‡0.602±0.018
BART ‡2.993±0.203 ‡0.711±0.016 ‡3.965±0.102 ‡0.632±0.015
Treatment Embedding ‡2.662±0.161 ‡0.724±0.013 ‡3.642±0.131 ‡0.670±0.015
TARNet ‡2.831±0.123 ‡0.711±0.013 ‡3.813±0.135 ‡0.663±0.009
CFR ‡2.822±0.121 ‡0.712±0.013 ‡3.792±0.134 ‡0.664±0.009
GNN ‡2.652±0.123 ‡0.720±0.010 ‡3.553±0.126 ‡0.681±0.010
GNN+MMD †2.596±0.162 †0.726±0.014 ‡3.531±0.136 ‡0.683±0.013
GraphITE (Proposed) 2.561±0.112 0.732±0.009 3.421±0.135 0.695±0.015
Denote by ptrain the probability distribution on X × T the training dataset D
follows, and by ptest the one for the test dataset. We assume that the test distribution
has the form of ptest(x, t) = pX (x)pT (t) because we want our model to perform well on
the distribution where treatments do not depend on the covariates.
For some (unknown target) function f∗ : X × T → Y and probability distribution
p over X × T , let the expected risk of our prediction model f : X × T → Y be
p(f) = E(x,t)∼p[`(f(x, t), f∗(x, t))]. (6)
Now, a natural extension of Proposition 2 by Lopez et al. (2020) gives the relation
between ptrain and ptest as
ptest(f) ≤ ptrain(f) + λ ·HSIC(φ, ψ). (7)
For (7) to hold, we require several conditions to hold: φ and ψ must be twice-
differentiable one-to-one mapping functions, and the HSIC must be defined using con-
tinuous, bounded, positive semi-definite kernels kΦ : Φ× Φ→ R. and kΨ : Ψ × Ψ → R.
The λ must also be theoretically determined based on the radius of the function space
in which f lies, but empirically, we simply treat it as a hyper-parameter.
The difference from Lopez et al. (2020) is that we also have the representation
function ψ for the treatments, which can be optimized alongside that for the input
covariates.
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Fig. 3: Sensitivity of the results to the regularization strength λ. Although the optimal
choices significantly improve the performance, at worst the other choices do not harm
the performance.
4 Experiments
We experimentally investigate the performance of the proposed GraphITE and its
merits of using the GNN and the HSIC regularization compared with various baseline
methods on two real-world datasets.
4.1 Datasets
We use two real-world datasets on drug responses: the Cancer Cell-Line Encyclopedia
(CCLE) dataset (Barretina et al., 2012) and Genomics of Drug Sensitivity in Cancer
(GDSC) dataset (Yang et al., 2012). Table 2 lists their basic statistics. CCLE is a rela-
tively small dataset with a moderate number of treatments, while GDSC has more than
100 treatments. Both of the datasets include IC50 values for drug–cell pairs, which are
known to be closely related to drug sensitivity. Namely, we define the drug sensitivity
as y = − log IC50 following previous studies (Lind and Anderson, 2019; Suphavilai,
Bertrand, and Nagarajan, 2018), which is the regression target in our experiments.
Both datasets are publicly available2 (Suphavilai, Bertrand, and Nagarajan, 2018).
Because we do not know the actual biases included in the original datasets, it is
not possible in principle to evaluate the performance of prediction models on unbiased
datasets. Therefore, we simply assume that the original datasets are complete and
2 https://github.com/CSB5/CaDRReS
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Fig. 4: Predictive performance depending on the bias coefficient η. A large η indicates
a larger selection bias. GraphITE shows its strong and stable tolerance to the biases
and consistently performs the best in the whole range.
Table 2: The statistics of datasets.
Dataset #Units #Treatments #Interaction
CCLE 491 24 11,054
GDSC 925 117 105,694
unbiased, and introduce additional synthetic biases to produce biased training datasets,
and then test the predictors obtained from them on the remainder. We introduce
synthetic treatment bias that assigns treatment t using t ∼ Categorical(softmax(ρy))
following previous studies (Schwab et al., 2020; Schwab, Linhardt, and Karlen, 2018).
The ρ = η
100σ
is a bias coefficient, where η is the magnitude of selection bias and σ is the
standard deviation of target values. A larger η indicates a higher selection probability;
intuitively, this indicates that scientists are more likely to conduct experiments for
drug–cell pairs with higher sensitivity values based on their expert knowledge and
experiences.
4.2 Baseline methods
The main features of GraphITE are the use of graph structures of treatments and bias
mitigation using HSIC regularization; therefore, we use versions without one or both
of these features as our baseline methods.
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Fig. 5: Predictive performance depending on the the number of treatments. Whereas
the baseline methods get degraded as the number of treatments increase, graphite
shows relatively robust to its increase and achieves the best performances, especially
in the larger dataset (GDSC).
We compare GraphITE with the following baselines: (i) Ordinary least squares lin-
ear regression (OLS), which concatenates two vectors, the covariate vector and treat-
ment vector coded as a one-hot vector, which is used as the input. (ii) Bayesian ad-
ditive regression trees (BART) (Chipman et al., 2010; Hill, 2011), which predicts the
outcomes by an ensemble of multiple regression trees; we used a Python implemen-
tation of BART3. (iii) Treatment embedding method, which exploits low-dimensional
representations of treatments to deal with a large number of treatments. Each treat-
ment is associated with a low-dimensional vector, which is input to a neural network,
as well as a covariate vector. Note that this method does not use the graph structures
of the treatments at all. (iv) TARNet (Shalit, Johansson, and Sontag, 2017), which is a
deep neural network model with shared layers for representation learning and different
layers for outcome prediction for treatment and control instances. (v) Counterfactual
regression (CFR) (Shalit, Johansson, and Sontag, 2017), which is a state-of-the-art
deep neural network model based on balanced representations between treatment and
control instances; we used the MMD as its IPM. Following previous studies (Yoon, Jor-
don, and van der Schaar, 2018; Saini et al., 2019), we extend the CFR (Shalit, Johans-
son, and Sontag, 2017) to the multiple-treatment setting; we regard the most frequent
treatment as the control treatment. We also tested several variants of GraphITE: (vi)
a variant with no bias mitigation that does not have the HSIC regularization term and
3 https://github.com/JakeColtman/bartpy
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Fig. 6: Predictive performance depending on treatment popularity. From the RMSE
results, the methods that do not rely on treatment graph information (CFR, TARNet,
BART) suffer from a lack of data especially for unpopular treatments. From the CI
results, the methods that have no bias mitigation mechanism put too much attentions
on popular treatments (i.e., difficult in terms of ranking) treatments, and perform
suboptimally. GraphITE shows the most stable and best performance on every group.
only uses a GNN, which we refer to as “GNN” hereafter and (vii) another variant using
MMD regularization instead of HSIC regularization. We used the same approach as
CFR to deal with multiple treatments. We denote it by “GNN+MMD”.
4.3 Experimental setting
As the evaluation metrics, we employ the root mean square error (RMSE) of all target–
treatment pairs in the test set defined as:
RMSE =
√√√√ 1
N test
1
| T |
Ntest∑
i=1
|T |∑
t=1
(yti − f(xi, t))2, (8)
where N test is the number of target individuals included in the test dataset. We also
employ the concordance index (CI) (Harrell Jr, Lee, and Mark, 1996) to evaluate
predictive performance in terms of ranking accuracy, which has been widely used in
previous studies (Kurilov, Haibe-Kains, and Brors, 2020; Safikhani et al., 2017). The
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CI is defined as
CI =
1
N test
Ntest∑
i=1
∑
t,u|yti>yui
θ(f(xi, t)− f(xi, u))
|{t, u | yti > yui }|
, (9)
where γ is the Heaviside step function defined as
θ(x) =

1, x > 0
0.5, x = 0
0 x < 0
. (10)
Note that the CI is identical to ROC-AUC when all outcomes are binary.
We split the whole data into 80%, 10%, and 10% for training, validation, and testing
set, respectively. We report the average results of 50 different trials. Note that while we
sample the factual treatments in the training and validation sets following the biased
sampling scenario explained in the Dataset section, all of the treatments are included
in the test set because we want our prediction model to perform uniformly well on all
treatments.
In GraphITE, to promote effective feature extraction from small data, we pre-
train the GNN ψ on regression tasks using three popular molecular datasets: ESOL,
FreeSolv, and Lipophilicity, provided by MoleculeNet (Wu et al., 2018)4. For the HSIC
regularization, we use the normalized version of the HSIC (nHSIC), defined as
nHSIC(KΦ,KΨ ) =
tr(KΦHKΨH)
‖KΦH‖‖KΨH‖ , (11)
where ‖ · ‖ denotes the Frobenius norm. The regularization parameter λ is optimized
in {10−3, 10−2, . . . , 103} based on the RMSE for the validation set. We set the number
of representation dimensions for target individuals and graph-structured treatments to
64 because we did not observe the significant differences in {16, 32, 64, 128} in the both
datasets. Similarly, we set the numbers of layers of φ, ψ, and g to 3.
4.4 Results
Table 1 summarizes the predictive performances of the different methods for η = 40
(i.e., the strongest bias). In the remainder, we report the experimental results when we
set η = 40 unless otherwise stated.
The deep learning-based methods (Treatment Embedding, TARNet, CFR) outper-
form the na¨ıve methods, such as Mean and OLS. BART also gives the comparable
performance. The existing bias mitigation methods that are simply extended to multi-
ple treatments (CFR and GNN+MMD) do not not show significant improvements over
the corresponding original ones (TARNet and GNN). By contrast, GraphITE achieves
the best performance, which is statistically significant against all the baselines, and it
demonstrates its effectiveness, especially on the larger dataset (GDSC). The merit of
exploiting the graph structures associated with treatments can also be seen in Table 1.
The GNN-based methods (shaded rows) perform better than the methods that neglect
graph-structured information.
4 http://moleculenet.ai/
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Figure 3 shows the sensitivity of the results to the strength of HSIC regularization;
although the optimal choices significantly improves the performance, none of the other
choices harm the performance. The results also highlight the effectiveness of the HSIC
as the choice for the regularization term; MMD shows no remarkable improvement
over the plain GNN because it cannot handle many treatments efficiently, whereas
GraphITE using HSIC regularization shows distinct improvements.
Now, we investigate the robustness of GraphITE against selection bias. Figure 4
shows the performances for different bias strengths, where a larger η represents a
larger selection bias. GraphITE shows its strong and stable tolerance to the biases
and consistently performs best under all bias strength settings.
The impacts of the number of treatments are shown in Fig. 5. For small num-
bers of treatments, both GraphITE and the other baseline methods perform similarly
well; however, the baseline methods, especially BART, degrade the performances as
the number increase. GNN+MMD does not show improvements from the plain GNN,
particularly on the larger dataset (GDSC). GraphITE shows the remarkable robustness
to the selection bias, even with large numbers of treatments.
Finally, we investigate the predictive performance based on treatment popularity, as
shown in Fig. 6. We focus on the treatment groups that are grouped by their popularity,
namely, the top 20%, 20–40%, 40–60%, 60–80% most popular treatment groups. As
can be seen from the RMSE results, the methods that do not rely on treatment graph
information (CFR, TARNet, and BART) suffer from a lack of training data especially
for unpopular treatments; On the other hand, the methods exploiting the auxiliary
information mitigate this problem.
Now we turn to the CI results. From its definition (9), CI measures ranking perfor-
mance. It is more difficult to estimate accurate ranking for popular treatments rather
than less popular treatments, because in our bias setting, more popular treatments
have higher outcomes, and they are more heterogeneous sets than less popular ones.5
The methods that have no bias mitigation mechanism put too much attentions on such
difficult treatments (in terms of ranking), and eventually perform suboptimally, while
GraphITE shows the most stable and best performance on every group.
5 Related Work
Treatment effect estimation. Treatment effect estimation is a practically impor-
tant task and has been widely studied in various fields ranging from healthcare (Eichler
et al., 2016) and economy (LaLonde, 1986) to education (Zhao and Heffernan, 2017).
One of the typical solutions is the matching method (Rubin, 1973; Abadie and Im-
bens, 2006), which compares the outcomes for pairs with similar covariates but different
treatments. The propensity score, which is the probability of a target individual re-
ceiving a treatment, is introduced to mitigate the curse of dimensionality and selection
bias (Rosenbaum and Rubin, 1983). Tree-based methods, such as Causal Forest (Wager
and Athey, 2018) and BART (Chipman et al., 2010; Hill, 2011), have also been pro-
posed and shown promising performances. Recently, representation learning based on
deep neural networks has been successfully applied to treatment effect estimation and
outperformed traditional methods (Shalit, Johansson, and Sontag, 2017; Johansson,
Shalit, and Sontag, 2016; Yao et al., 2018).
5 On the other hand, it is rather easy to obtain low RMSEs for popular treatments
because their outcomes have low variances.
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Most previous studies have focused on binary treatments, and extensions to mul-
tiple types of treatments, especially high numbers, are key research directions. There
have been several approaches designed for multiple treatments (Schwab, Linhardt, and
Karlen, 2018; Wager and Athey, 2018; Chipman et al., 2010); however, most of them
are limited to a relatively small number of treatments, making it difficult to consider
more than a few dozen treatments. Saini et al. (2019) whose motivation was somewhat
similar to ours, considered combinatorial treatments; however, their focus was on a
large number of combinations made from a small number of treatments, whereas we
focus on many single treatments with the help of information on the treatments.
Extensions to real-valued treatments are also important for real-world applications,
such as estimation of appropriate drug dosages (Schwab et al., 2020; Imbens, 2000).
Wang et al. (2020) proposed an interesting approach to learn input representations that
cannot distinguish real-valued domains. Lopez et al. (2020) considered total-ordered
treatment spaces. They proposed HSIC regularization for dealing with biased observa-
tional data; the theory of our proposed GraphITE is based on their theoretical frame-
work, but we extend the implications of their framework to representation learning of
treatments with rich features.
Graph neural networks. The GNN is one of the most successful deep neural net-
work architectures owing to the practical importance of graph-structured data, and it
has significantly improved the performance on various graph-structured data analysis
tasks, such as node classification (Kipf and Welling, 2016), graph classification (Duve-
naud et al., 2015; Gilmer et al., 2017), and link prediction (Zhang and Chen, 2018),
beyond conventional methods (Hamilton, Ying, and Leskovec, 2017; Henaff, Bruna,
and LeCun, 2015). In the field of chemo-informatics, GNNs have particularly flour-
ished and played an important role in predicting molecule properties (Duvenaud et al.,
2015; Schu¨tt et al., 2018; Gilmer et al., 2017), finding interactions between chemical ob-
jects (Harada et al., 2020), and generating desirable and unique molecules (You et al.,
2018; Zang and Wang, 2020). GraphITE also relies on their powerful ability to extract
features from graph-structured treatments.
Theoretical analysis of the expressive power of GNNs has been of great interest to
researchers, for example, in their invertibility (Xu et al., 2018; Murphy et al., 2019;
Zang and Wang, 2020; Liu et al., 2019). GraphITE theoretically requires this property
although it does not hold for most practical GNNs; however, a non-invertible GNN
shows satisfactory performance in practice, as shown in the experimental section.
Recently, several studies have considered causal inference in graph-structured input
domains (Guo, Li, and Liu, 2020; Alvari et al., 2019; Veitch, Wang, and Blei, 2019;
Harada and Kashima, 2020; Ma, Wang, and Tresp, 2020), where the input space has
a graph structure representing proximal relations among target individuals. However,
to the best of our knowledge, no study has explored treatment effect estimation with
graph-structured treatments, which is at the intersection of the above two topics of
practical importance.
6 Conclusion
In this study, we proposed GraphITE, which considers graph-structured treatment.
Our method, which is based on a GNN and HSIC regularizaiton, allows us to not
only improve estimation accuracy but deal with a large number of treatments given
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biased observational data. In experiments on two real-world drug response datasets,
GraphITE achieved the best performances in terms of RMSE and CI when compared
to the competitive baselines. In particular, we observed a significant improvement over
baselines when the effect of selection bias and number of treatments were large. A
potential future direction is to consider other types of complex structured data, such
as text, images, and videos.
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